InvestorsHub Logo

georgebailey

08/24/23 11:02 AM

#623913 RE: ATLnsider #623900

ATL I may disagree with you on that - just because poly is integral doesn’t mean poly is not named.
However, I’ve noticed that sometimes poly is mentioned in past presentations and on slides. Yes, The current trial receiving NIH funding that spurred this dialogue no mention of Poly- maybe it stays that way.
In addition, not mentioning Poly is a big deal because it improves DCVax by 4x.
the meat and potatoes of my question- if we set aside the component nature- is an RA filing including Poly enough to not mention /promote poly?

Pharmboy46

08/24/23 1:52 PM

#624097 RE: ATLnsider #623900

I realize that Poly LCIC was used in the most recent trials but, I’m trying not to get too hung up on it being the only immuno- stimulant out there. If I remember correctly imiquimod (and possibly others can be used?)